Swiss National Bank’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-256,600
| Closed | -$387K | – | 2633 |
|
|
2023
Q1 | $387K | Buy |
256,600
+8,800
| +4% | +$13.3K | ﹤0.01% | 2579 |
|
|
2022
Q4 | $620K | Sell |
247,800
-30,900
| -11% | -$77.3K | ﹤0.01% | 2525 |
|
|
2022
Q3 | $1.18M | Buy |
278,700
+38,000
| +16% | +$160K | ﹤0.01% | 2247 |
|
|
2022
Q2 | $672K | Buy |
240,700
+11,700
| +5% | +$32.7K | ﹤0.01% | 2535 |
|
|
2022
Q1 | $1.31M | Buy |
229,000
+15,300
| +7% | +$87.5K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $1.95M | Hold |
213,700
| – | – | ﹤0.01% | 2076 |
|
|
2021
Q3 | $2.28M | Buy |
213,700
+22,300
| +12% | +$238K | ﹤0.01% | 1968 |
|
|
2021
Q2 | $2.97M | Sell |
191,400
-5,800
| -3% | -$90K | ﹤0.01% | 1840 |
|
|
2021
Q1 | $3.2M | Buy |
197,200
+2,000
| +1% | +$32.4K | ﹤0.01% | 1720 |
|
|
2020
Q4 | $4.13M | Hold |
195,200
| – | – | ﹤0.01% | 1476 |
|
|
2020
Q3 | $2.89M | Buy |
195,200
+4,200
| +2% | +$62.2K | ﹤0.01% | 1523 |
|
|
2020
Q2 | $2.81M | Buy |
191,000
+25,100
| +15% | +$369K | ﹤0.01% | 1514 |
|
|
2020
Q1 | $1.95M | Buy |
165,900
+5,100
| +3% | +$59.9K | ﹤0.01% | 1475 |
|
|
2019
Q4 | $3.78M | Buy |
160,800
+19,600
| +14% | +$461K | ﹤0.01% | 1334 |
|
|
2019
Q3 | $2.61M | Buy |
141,200
+3,000
| +2% | +$55.5K | ﹤0.01% | 1501 |
|
|
2019
Q2 | $2.57M | Buy |
138,200
+10,200
| +8% | +$190K | ﹤0.01% | 1543 |
|
|
2019
Q1 | $3.13M | Buy |
128,000
+4,300
| +3% | +$105K | ﹤0.01% | 1376 |
|
|
2018
Q4 | $3.21M | Buy |
123,700
+10,700
| +9% | +$278K | ﹤0.01% | 1257 |
|
|
2018
Q3 | $3.58M | Buy |
113,000
+12,700
| +13% | +$402K | ﹤0.01% | 1346 |
|
|
2018
Q2 | $3.9M | Hold |
100,300
| – | – | ﹤0.01% | 1260 |
|
|
2018
Q1 | $2.77M | Buy |
100,300
+1,800
| +2% | +$49.7K | ﹤0.01% | 1430 |
|
|
2017
Q4 | $1.78M | Buy |
98,500
+20,000
| +25% | +$362K | ﹤0.01% | 1711 |
|
|
2017
Q3 | $1.27M | Hold |
78,500
| – | – | ﹤0.01% | 1913 |
|
|
2017
Q2 | $1.09M | Buy |
78,500
+5,900
| +8% | +$81.7K | ﹤0.01% | 2003 |
|
|
2017
Q1 | $1.09M | Buy |
72,600
+20,700
| +40% | +$311K | ﹤0.01% | 1975 |
|
|
2016
Q4 | $680K | Hold |
51,900
| – | – | ﹤0.01% | 2251 |
|
|
2016
Q3 | $894K | Hold |
51,900
| – | – | ﹤0.01% | 2040 |
|
|
2016
Q2 | $937K | Buy |
51,900
+1,500
| +3% | +$27.1K | ﹤0.01% | 2004 |
|
|
2016
Q1 | $925K | Buy |
50,400
+9,200
| +22% | +$169K | ﹤0.01% | 1942 |
|
|
2015
Q4 | $1.1M | Buy |
+41,200
| New | +$1.1M | ﹤0.01% | 1756 |
|